John Hohneker
Independent Board Member, Consultant, and Advisor
- Role
- Member, Board of Directors at Artios
- Location
- Las Vegas, NV, US
- LinkedIn followers
- 500 followers
About John Hohneker
As an oncologist and pharmaceutical leader, I have always put patient needs as my first priority. While my career has been primarily focused on cancer, I have also focused on diseases in immunology, dermatology, and rheumatology as well as transplantation. I have played a critical role in the development, approval and/or commercialization of many landmark products, including Gleevec/Glivec, Femara, Zometa, Tasigna, Afinitor, Certican/Zortress, Ilaris, Xolair and Cosentyx.
Experience
Member, Board of Directors
Sep 2024 — Present · Cambridge, GB
Artios Pharma, is a clinical stage biotechnology company that focuses on DNA damaging response pathways to treat cancer
Education
Rutgers Robert Wood Johnson Medical School
MD, Medicine
1981 — 1985
Gettysburg College
BA, Chemistry
1977 — 1981
Skills
- Drug Development
- Cancer
- Gcp
- CRO Management
- Market Access
- CRO
- Clinical Trials
- Clinical Development
- Biotechnology
- Therapeutic Areas
- Clinical Research
- Pharmaceutical Industry
- Regulatory Affairs
- Lifesciences
- Medical Writing
- Nephrology
- Oncology
- Healthcare
- Neurology
- Medical Affairs
- Product Launch
- Immunology
- Good Clinical Practice (Gcp)
- Hospitals
- Transplant
- Life Sciences
- Hematology
- Infectious Diseases
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.